Novel HER2 activity linked to therapy resistance and brain metastasis

First Author / 第一作者

Kieu-Thanh Huynh

Institution / 單位

Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taiwan

Audio / 音訊檔

Author Group / 作者群

Ya-Ling Wei, M.S.1,2, Hsiao-Fan Chen, Ph.D.1,2,3, Chiung-Wen Mary Chang, Ph.D.4, Jin-Han Yao, M.D.5,6, Shu-Wei Hu, Ph.D.1,2, Chih-Hao Huang, M.D.2,7, Hsiu-Yun Liao, M.S.N8, Kai-Cheng Hsu, Ph.D.9, Liang-Chih Liu, M.D. , Ph.D.6,7, Mien-Chie Hung, Ph.D.1,2,10,#, Wei-Chien Huang, Ph.D.1,2, 10,11,#

Author Group Institution/ 作者群單位

1Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan. 2Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan. 3Graduate Institute of Cell Biology, China Medical University, Taichung, Taiwan. 4Graduate Institute of Biochemistry and Molecular Biology, China Medical University, Taichung, Taiwan. 5Department of Cardiology, China Medical University Hospital, Taichung, Taiwan. 6School of Medicine, China Medical University, Taichung, Taiwan. 7Division of Breast Surgery, China Medical University Hospital, Taichung, Taiwan. 8Department of Hematology-Oncology, E-Da Cancer Hospital, Kaohsiung, Taiwan. 9Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan. 10Cancer Biology and Precision Therapeutics Center, China Medical University, Taichung, Taiwan. 11Department of Medical Research, China Medical University Hsinchu Hospital, Hsinchu, Taiwan.

Category / 主題分類

Basic Research

Keyword / 關鍵字

Breast cancer, HER2, lapatinib, brain metastasis

Back to list